全身性甲减与MCT8缺陷小鼠模型的脑基因表达:Mct8-Oatp1c1-Dio2三联体
该研究利用RNA测序比较了甲状腺阻断所致全身性甲减(SH)小鼠与Slc16a2/Slco1c1(MO)、Slc16a2/Dio2(MD)双敲除小鼠在生后21-23天大脑皮质和纹状体的基因表达。三种条件下基因表达模式各不相同且仅部分重叠,SH的基因表达变化范围更广、程度最高,部分源于对甲减的继发性基因反应;原发转录T3靶基因重叠更紧密,但定量反应显示SH比MD或MO更严重。结论提示AHDS的神经损害过于严重,不能仅用甲状腺激素缺乏来解释。
要点
- SH小鼠脑基因表达变化范围最广、程度最高,部分为继发性反应。
- 原发转录T3靶基因在三种模型中重叠更紧密,但SH反应仍重于MD和MO。
- 细胞类型富集基因提示三种条件的细胞层面受累存在差异。
核心结论
- AHDS的神经损害过于严重,不能仅用甲状腺激素缺乏来解释。
- 三种条件(SH、MD、MO)的脑基因表达模式不同且仅部分重叠。
- SH的基因表达变异范围最广、程度最高,部分源于对甲减的继发性基因反应。
- 原发转录T3靶基因重叠更紧密,但定量反应显示SH比MD或MO更严重。
研究设计与样本
- 研究对生后21-23天小鼠的大脑皮质和纹状体进行RNA测序。
- 比较甲状腺阻断所致全身性甲减(SH)小鼠与Slc16a2/Slco1c1(MO)和Slc16a2/Dio2(MD)双敲除小鼠。
- 用实时聚合酶链反应在重复生物样本中确认RNA-Seq结果。
- 通过细胞类型富集基因评估细胞类型受累情况。
- 基于概率图模型的功能节点活性分析功能基因组差异。
主要发现
- 三种条件各自呈现不同的基因表达模式,但存在部分重叠。
- SH的基因表达变化比MD或MO更广泛且幅度最高。
- SH变化部分归因于对甲减的继发性基因反应。
- 原发转录T3靶基因集重叠更紧密,但SH的定量基因反应比MD或MO更严重。
- 细胞类型富集基因检查提示三种条件之间存在细胞层面差异。
临床怎么用
- 结果提示评估AHDS神经损害时不应仅归因于甲状腺激素缺乏。
- MO与MD双敲除小鼠可作为研究AHDS的模型,但各有不同的脑基因表达谱。
- 解读小鼠MCT8缺陷模型时需注意其与全身性甲减的脑转录组差异。
局限性
- 研究基于小鼠模型,结果外推至人类AHDS需谨慎。
- RNA测序仅取材于大脑皮质和纹状体,未覆盖其他脑区。
- 研究时间点为生后21-23天,未反映其他发育阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The monocarboxylate transporter 8 (Mct8) protein is a primary thyroxine (T4) and triiodothyronine (T3) (thyroid hormone [TH]) transporter. Mutations of the MCT8-encoding, SLC16A2 gene alter thyroid function and TH metabolism and severely impair neurodevelopment (Allan-Herndon-Dudley syndrome [AHDS]). Mct8-deficient mice manifest thyroid alterations but lack neurological signs. It is believed that Mct8 deficiency in mice is compensated by T4 transport through the Slco1c1-encoded organic anion transporter polypeptide 1c1 (Oatp1c1). This allows local brain generation of sufficient T3 by the Dio2-encoded type 2 deiodinase, thus preventing brain hypothyroidism. The Slc16a2/Slco1c1 (MO) and Slc16a2/Dio2 (MD) double knockout (KO) mice lacking T4 and T3 transport, or T3 transport and T4 deiodination, respectively, should be appropriate models of AHDS. Our goal was to compare the cerebral hypothyroidism of systemic hypothyroidism (SH) caused by thyroid gland blockade with that present in the double KO mice. Methods: We performed RNA sequencing by using RNA from the cerebral cortex and striatum of SH mice and the double KO mice on postnatal days 21-23. Real-time polymerase chain reaction was used to confirm RNA-Seq results in replicate biological samples. Cell type involvement was assessed from cell type-enriched genes. Functional genomic differences were analyzed by functional node activity based on a probabilistic graphical model. Results: Each of the three conditions gave a different pattern of gene expression, with partial overlaps. SH gave a wider and highest variation of gene expression than MD or MO. This was partially due to secondary gene responses to hypothyroidism. The set of primary transcriptional T3 targets showed a tighter overlap, but quantitative gene responses indicated that the gene responses in SH were more severe than in MD or MO. Examination of cell type-enriched genes indicated cellular differences between the three conditions. Conclusions: The results indicate that the neurological impairment of AHDS is too severe to be fully explained by TH deprivation only.
引用
- Morte B, Gil-Ibañez P, Heuer H, et al. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad. Thyroid. 2021. PMID: 33307956. doi:10.1089/thy.2020.0649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。